Philip Hoffman to Precision Medicine
This is a "connection" page, showing publications Philip Hoffman has written about Precision Medicine.
Connection Strength
0.152
-
Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation. Oncotarget. 2016 Apr 05; 7(14):18876-86.
Score: 0.089
-
Personalized treatment of lung cancer. Semin Oncol. 2011 Apr; 38(2):274-83.
Score: 0.063